Catheter based treatments for fibrosing mediastinitis

Erin A. Fender, R. Jay Widmer, Erica M. Knavel Koepsel, John P. Welby, Ryan Kern, Tobias Peikert, Haraldur Bjarnason, David R. Holmes

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. While structural interventions aimed at alleviating obstruction can provide significant palliation, surgical interventions are challenging with high mortality and clinical experience with percutaneous interventions is limited. Here, we will review the presentation, natural history, and treatment of fibrosing mediastinitis, placing particular emphasis on catheter-based therapies.

Original languageEnglish (US)
Pages (from-to)878-885
Number of pages8
JournalCatheterization and Cardiovascular Interventions
Volume94
Issue number6
DOIs
StatePublished - Nov 15 2019

Fingerprint

Catheters
Histoplasmosis
Mediastinum
Natural History
Esophagus
Anti-Inflammatory Agents
Therapeutics
Mortality
Infection
Mediastinal Fibrosis

Keywords

  • histoplasmosis
  • pulmonary artery stenosis
  • pulmonary artery stent
  • pulmonary vein stenosis
  • pulmonary vein stent

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Fender, E. A., Widmer, R. J., Knavel Koepsel, E. M., Welby, J. P., Kern, R., Peikert, T., ... Holmes, D. R. (2019). Catheter based treatments for fibrosing mediastinitis. Catheterization and Cardiovascular Interventions, 94(6), 878-885. https://doi.org/10.1002/ccd.28152

Catheter based treatments for fibrosing mediastinitis. / Fender, Erin A.; Widmer, R. Jay; Knavel Koepsel, Erica M.; Welby, John P.; Kern, Ryan; Peikert, Tobias; Bjarnason, Haraldur; Holmes, David R.

In: Catheterization and Cardiovascular Interventions, Vol. 94, No. 6, 15.11.2019, p. 878-885.

Research output: Contribution to journalArticle

Fender, EA, Widmer, RJ, Knavel Koepsel, EM, Welby, JP, Kern, R, Peikert, T, Bjarnason, H & Holmes, DR 2019, 'Catheter based treatments for fibrosing mediastinitis', Catheterization and Cardiovascular Interventions, vol. 94, no. 6, pp. 878-885. https://doi.org/10.1002/ccd.28152
Fender EA, Widmer RJ, Knavel Koepsel EM, Welby JP, Kern R, Peikert T et al. Catheter based treatments for fibrosing mediastinitis. Catheterization and Cardiovascular Interventions. 2019 Nov 15;94(6):878-885. https://doi.org/10.1002/ccd.28152
Fender, Erin A. ; Widmer, R. Jay ; Knavel Koepsel, Erica M. ; Welby, John P. ; Kern, Ryan ; Peikert, Tobias ; Bjarnason, Haraldur ; Holmes, David R. / Catheter based treatments for fibrosing mediastinitis. In: Catheterization and Cardiovascular Interventions. 2019 ; Vol. 94, No. 6. pp. 878-885.
@article{d7bfdf31ffa146988f1db029e0f26433,
title = "Catheter based treatments for fibrosing mediastinitis",
abstract = "Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. While structural interventions aimed at alleviating obstruction can provide significant palliation, surgical interventions are challenging with high mortality and clinical experience with percutaneous interventions is limited. Here, we will review the presentation, natural history, and treatment of fibrosing mediastinitis, placing particular emphasis on catheter-based therapies.",
keywords = "histoplasmosis, pulmonary artery stenosis, pulmonary artery stent, pulmonary vein stenosis, pulmonary vein stent",
author = "Fender, {Erin A.} and Widmer, {R. Jay} and {Knavel Koepsel}, {Erica M.} and Welby, {John P.} and Ryan Kern and Tobias Peikert and Haraldur Bjarnason and Holmes, {David R.}",
year = "2019",
month = "11",
day = "15",
doi = "10.1002/ccd.28152",
language = "English (US)",
volume = "94",
pages = "878--885",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Catheter based treatments for fibrosing mediastinitis

AU - Fender, Erin A.

AU - Widmer, R. Jay

AU - Knavel Koepsel, Erica M.

AU - Welby, John P.

AU - Kern, Ryan

AU - Peikert, Tobias

AU - Bjarnason, Haraldur

AU - Holmes, David R.

PY - 2019/11/15

Y1 - 2019/11/15

N2 - Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. While structural interventions aimed at alleviating obstruction can provide significant palliation, surgical interventions are challenging with high mortality and clinical experience with percutaneous interventions is limited. Here, we will review the presentation, natural history, and treatment of fibrosing mediastinitis, placing particular emphasis on catheter-based therapies.

AB - Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. While structural interventions aimed at alleviating obstruction can provide significant palliation, surgical interventions are challenging with high mortality and clinical experience with percutaneous interventions is limited. Here, we will review the presentation, natural history, and treatment of fibrosing mediastinitis, placing particular emphasis on catheter-based therapies.

KW - histoplasmosis

KW - pulmonary artery stenosis

KW - pulmonary artery stent

KW - pulmonary vein stenosis

KW - pulmonary vein stent

UR - http://www.scopus.com/inward/record.url?scp=85075114639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075114639&partnerID=8YFLogxK

U2 - 10.1002/ccd.28152

DO - 10.1002/ccd.28152

M3 - Article

C2 - 30790443

AN - SCOPUS:85075114639

VL - 94

SP - 878

EP - 885

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 6

ER -